Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
SEOUL, South Korea--(BUSINESS WIRE)--Oct 23, 2023--
Source: eagletribune.com
Stay updated with breaking news from Nutritional Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SEOUL, South Korea--(BUSINESS WIRE)--Oct 23, 2023--